THIRD-PARTY GMP AUDITS FOR FIRMS WITH GOOD COMPLIANCE RECORD UNDER CONSIDERATION BY FDA, DYKSTRA SAYS; "PARTNERSHIP" WITH INDUSTRY EMPHASIZED
This article was originally published in The Gray Sheet
Executive Summary
FDA use of outside groups to perform good manufacturing practices inspections could focus on firms with good compliance track records, Deputy Associate Commissioner for Regulatory Affairs Gary Dysktra told the annual meeting of the Food and Drug Law Institute (FDLI) in Washington, D.C. Dec. 13.